7 research outputs found

    La farmacovigilancia como herramienta de promoción y prevención de los riesgos asociados con los medicamentos

    Get PDF
    Los problemas relacionados con medicamentos son una de las principales causas de los fallos terapéuticos, ocasionando que se comprometa la seguridad del paciente, lo que genera altos costos al sistema de salud, a la familia y al paciente que puede hasta perder la vida, estos procesos de dispensación, recepción y almacenamiento, que no se realizan bien por diversas situaciones, en las que las fallas más comunes son los errores humanos por falta de capacitación por querer hacer las con velocidad para evacuar usuario del servicio farmacéutico, por estrés o cansancio, ha forzado a que cada día se exija de manera más rigurosa el cumplimiento del programa de Farmacovigilancia, que tiene por objetivos adelantar acciones que se encaminen a prevención y promoción del uso de los medicamentos, mediante protocolos, planes y estrategias, con las que se logre la eficiencia, la eficacia y la calidad de la prestación del servicio. Por medio de esta investigación se realiza una búsqueda de referencia bibliográficas, con las que se pueda presentar la estructura de un programa de farmacovigilancia en el que se prevengan acciones que afecten al usuario, y con las que se fortalezcan los procesos que se deben realizar dentro de un servicio farmacéutico, anticipándose a los errores, disminuyendo los problemas de atención a la salud, documentando, implementando y gestionando las habilidades de quienes hacen parte del servicio.Drug-related problems are one of the main causes of therapeutic failures, causing patient safety to be compromised, which generates high costs for the health system, the family and the patient who may even lose their lives, these processes of dispensing, reception and storage, which are not carried out well due to various situations, in which the most common failures are human errors due to lack of training for wanting to do things quickly to evacuate the user from the pharmaceutical service, due to stress or fatigue, has forced to demand more rigorously every day compliance with the Pharmacovigilance program, whose objectives are to carry out actions aimed at preventing and promoting the use of medicines, through protocols, plans and strategies, with which the efficiency, effectiveness and quality of service provision. Through this research, a bibliographic reference search is carried out, with which the structure of a pharmacovigilance program can be presented in which actions that affect the user are prevented, and with which the processes that must be carried out within the framework are strengthened. of a pharmaceutical service, anticipating errors, reducing health care problems, documenting, implementing, and managing the skills of those who are part of the service

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)

    No full text
    The original version of this article unfortunately contained a mistake. The members of the ESICM Trials Group Collaborators were not shown in the article but only in the ESM. The full list of collaborators is shown below. The original article has been corrected
    corecore